192 related articles for article (PubMed ID: 29494271)
1. Molecular identification and in vitro antifungal susceptibility of Scedosporium complex isolates from high-human-activity sites in Mexico.
Elizondo-Zertuche M; de J Treviño-Rangel R; Robledo-Leal E; Luna-Rodríguez CE; Martínez-Fierro ML; Rodríguez-Sánchez IP; González GM
Mycologia; 2017; 109(6):874-881. PubMed ID: 29494271
[TBL] [Abstract][Full Text] [Related]
2. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex.
Hedayati MT; Tavakoli M; Maleki M; Heidari S; Mortezaee V; Gheisari M; Hassanzad M; Mirenayat MS; Mahdaviani SA; Pourabdollah M; Velayati AA; Vakili M; Abastabar M; Haghani I; Jafarzadeh J; Hedayati N; Seyedmousavi S; Alastruey-Izquierdo A
Microb Pathog; 2019 Apr; 129():168-175. PubMed ID: 30742949
[TBL] [Abstract][Full Text] [Related]
3. Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients.
Elizondo-Zertuche M; Montoya AM; Robledo-Leal E; Garza-Veloz I; Sánchez-Núñez AL; Ballesteros-Elizondo R; González GM
Mycopathologia; 2017 Aug; 182(7-8):681-689. PubMed ID: 28456868
[TBL] [Abstract][Full Text] [Related]
4. New record of Scedosporium dehoogii from Chile: Phylogeny and susceptibility profiles to classic and novel putative antifungal agents.
Alvarez E; Sanhueza C
Rev Iberoam Micol; 2016; 33(4):224-229. PubMed ID: 27461998
[TBL] [Abstract][Full Text] [Related]
5. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
[TBL] [Abstract][Full Text] [Related]
6. Environmental Screening for the Scedosporium apiospermum Species Complex in Public Parks in Bangkok, Thailand.
Luplertlop N; Pumeesat P; Muangkaew W; Wongsuk T; Alastruey-Izquierdo A
PLoS One; 2016; 11(7):e0159869. PubMed ID: 27467209
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of conventional antifungal agents against Scedosporium apiospermum isolates recovered from clinical and environmental samples in Nigeria.
Nweze EI; Okafor JI
Acta Microbiol Immunol Hung; 2010 Sep; 57(3):209-14. PubMed ID: 20870592
[TBL] [Abstract][Full Text] [Related]
8. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia.
Flórez-Muñoz SV; Alzate JF; Mesa-Arango AC
Mycopathologia; 2019 Feb; 184(1):53-63. PubMed ID: 30554299
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: a case report and review of the literature.
Tóth EJ; Nagy GR; Homa M; Ábrók M; Kiss IÉ; Nagy G; Bata-Csörgő Z; Kemény L; Urbán E; Vágvölgyi C; Papp T
Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):31. PubMed ID: 28410611
[TBL] [Abstract][Full Text] [Related]
10. Polycytella hominis is a mutated form of Scedosporium apiospermum.
Borman AM; Campbell CK; Linton CJ; Bridge PD; Johnson EM
Med Mycol; 2006 Feb; 44(1):33-9. PubMed ID: 16805091
[TBL] [Abstract][Full Text] [Related]
11. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
12. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
13. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.
Meletiadis J; Meis JF; Mouton JW; Rodriquez-Tudela JL; Donnelly JP; Verweij PE;
Antimicrob Agents Chemother; 2002 Jan; 46(1):62-8. PubMed ID: 11751112
[TBL] [Abstract][Full Text] [Related]
16. The environmental source of emerging Apophysomyces variabilis infection in India.
Prakash H; Ghosh AK; Rudramurthy SM; Paul RA; Gupta S; Negi V; Chakrabarti A
Med Mycol; 2016 Aug; 54(6):567-75. PubMed ID: 27118802
[TBL] [Abstract][Full Text] [Related]
17. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
Lackner M; Fernández-Silva F; Guarro J; Lass-Flörl C
J Antimicrob Chemother; 2014 Nov; 69(11):3027-32. PubMed ID: 24986494
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
[TBL] [Abstract][Full Text] [Related]
19. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.
Lackner M; Rezusta A; Villuendas MC; Palacian MP; Meis JF; Klaassen CH
Mycoses; 2011 Oct; 54 Suppl 3():12-21. PubMed ID: 21995658
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous hyalohyphomycosis by Scedosporium apiospermum in an immunocompromised patient.
Makino K; Fukushima S; Maruo K; Egawa K; Nishimoto K; Ihn H
Mycoses; 2011 May; 54(3):259-61. PubMed ID: 19889175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
